Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights

Go back to Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Misses Q2 EPS by 45c

August 13, 2020 4:17 PM EDT

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($1.04), $0.45 worse than the analyst estimate of ($0.59).

"Amidst an incredibly challenging economic landscape, I am pleased to report Arcadia has achieved a number of key milestones across each of the crop product areas in which we innovate: hemp, wheat and soy," said Matthew Plavan, president and CEO of... More